Fundraising Fox
/People
Sign in

Hans Ivar Robinson

Investor

CEO/Chairman at Birk Venture · Partner at Practica Capital

Oslo, Oslo, Norway

Find your path to Hans

454 people in our graph share verified history with Hans — schools, employers, funds. One of them is your warm intro.

Miguel ForteunlockedHans: together at Zelluna Immunotherapy (2017–2019)
×6Hans: together at Practica Capital
×5Hans: together at Pfizer

About

Founder of Birk Venture (2010) with 25 years of experience in the pharmaceutical and biotech industry, including leadership roles at AstraZeneca, Pfizer and Pronova Biopharma. He has extensive experience with capital raising, private placements, mergers and IPOs, and holds an M.Sc. from the Norwegian School of Economics (NHH).

Contact· self-published, not guessed

Experience

  1. APIM TherapeuticsNon Executive Directorcurrent2026 — presentOslo, Norway
  2. Zelluna ImmunotherapyCo-Founder and Non Executive Directorcurrent2024 — present
  3. Zelluna ImmunotherapyChairman and Co-Founder2018 — 2023Oslo, Oslo, Norway
  4. Zelluna ImmunotherapyCo-Founder and Director2016 — 2018Oslo
  5. Nextera ASExecutive Chairman and Co-foundercurrent2023 — presentOslo, Norway
  6. Nextera ASChairman and Co-founder2012 — 2023Oslo
  7. Accession Therapeutics LimitedCo-Founding Investorcurrent2025 — present
  8. Accession Therapeutics LimitedNon-executive Director and Co-Founding Investor2021 — 2025United Kingdom
  9. Birk Venture ASCEO and Foundercurrent2010 — presentOslo
  10. APIM Therapeutics ASNon-executive Director2011 — 2017Trondheim
  11. TargovaxNon-executive Director2012 — 2015
  12. BerGenBio ASNon-executive Director2011 — 2015
  13. Pronova BiopharmaVice President Pharmaceuticals / VP and Head of Business Development2006 — 2009Oslo
  14. AstraZenecaRegional Business Director, Europe / VP Sales & Marketing1995 — 2006Brussels/London/Oslo
  15. PharmaciaSales representative / Regional Sales Manager1993 — 1995Oslo
  16. PfizerTrainee Management1992New York, US

Skills & more

Biotechnology8Lifesciences11Oncology20Drug Discovery7Drug Development9Market Access12Pharmaceutical Sales1Clinical Trials2Business Strategy5Clinical Development5Sales Effectiveness5Commercialization4
+10 moreRegulatory AffairsLife SciencesProduct LaunchCardiologyInfectious DiseasesNon-Executive DirectorTechnology TransferPharmaceutical IndustryStrategyManagement

From Hans's professional profile.

Colleagues at Birk Venture

Per-Oluf Olsen
Co-investor and external partner at Birk Venture

Frequently asked questions

Who is Hans Ivar Robinson?
Founder of Birk Venture (2010) with 25 years of experience in the pharmaceutical and biotech industry, including leadership roles at AstraZeneca, Pfizer and Pronova Biopharma. He has extensive experience with capital raising, private placements, mergers and IPOs, and holds an M.Sc. from the Norwegian School of Economics (NHH).
Where does Hans Ivar Robinson work?
Hans Ivar Robinson is CEO/Chairman at Birk Venture.
Where did Hans Ivar Robinson go to school?
Hans Ivar Robinson studied at IMD (Program for Excecutive Development); University of Bergen (UiB) (Law); Norwegian School of Economics (NHH) (Master in Science of Business (Siviløkonom)).

Same school

Shared employers

Also worked at Zelluna Immunotherapy1

Miguel ForteAdvisor at Delin Ventures